Skip to Main Content

Paper Details

ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis.
Pediatr Crit Care Med
324
2006
Author NameAffiliation
Brahm GoldsteinOregon Health and Science University
  • 1 - 1

Datasets

Release 1.2